Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy

Growth Factors

Volumn 29, Issue 1, 2011, Pages 8-13

  Hahn, Won Ho ^a   Suh, Jin Soon ^a   Cho, Byoung Soo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Childhood pediatric; IGF 1 gene; Insulin like growth factor 1 receptor; Nephrology; Polymorphism

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; NEPHROSIS; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, IGF TYPE 1; REPUBLIC OF KOREA;

EID: 78651366679     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2010.532126     Document Type: Article

References (31)

1. Allen DB, Fogo A, el-Hayek R, Langhough R, Friedman AL. 1992. Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr Res 31:406-410.
2. Alric C, Pecher C, Cellier E, Schanstra JP, Poirier B, Chevalier J, Bascands JL, Girolami JP 2002. Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int 62:412-421.
3. Ballardie FW, Gordon MT, Sharpe PT, Darvill AM, Cheng H. 1994. Intrarenal cytokine mRNA expression and location in normal and IgA nephropathy tissue: TGF alpha, TGF beta, IGF 1, IL-4 and IL-6. Nephrol Dial Transplant 9:1545-1552.
4. Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, Fagerheim T, Bremnes Y, Chanock SJ, Burdett L, Yeager M, Ursin G, Kristensen VN. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics 3:9.
5. Bridgewater DJ, Matsell DG. 2003. Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis. Pediatr Nephrol 18:1109-1115.
6. Bridgewater DJ, Ho J, Sauro V, Matsell DG 2005. Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. Kidney Int 67:1308-1314.
7. Chertin B, Farkas A, Puri P. 2004. Insulin-like growth factor-1 expression in reflux nephropathy. Pediatr Surg Int 20: 283-289. (Pubitemid 38899936)
8. Davis LK, Rodgers BD, Kelley KM. 2008. Angiotensin II-and glucose-stimulated extracellular matrix production: Mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line. Endocrine 33:32-39.
9. Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH. 2003. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling. J Cell Biochem 88:802-811.
10. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y. 2002. A putative functional polymorphism in the IGF-I gene: Association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51: 2313-2316.
11. Frystyk J, Freda P, Clemmons DR. 2010. The current status of IGF-Iassays\A2009 update. Growth Horm IGF Res 20:8-18.
12. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
13. Giordano M, DeFronzo RA. 1995. Acute effect of human recombinant insulin-like growth factor I on renal function in humans. Nephron 71:10-15.
14. Goumenos DS, Kalliakmani P, Tsakas S, Papachristou E, Vlachojannis JG. 2008. Growth factors and apoptosis-related protein expression in human crescentic nephritis. Med Sci Monit 14:BR243-BR248.
15. Hedrick PW. 1987. Gametic disequilibrium measures: Proceed with caution. Genetics 117:331-341.
16. Hirschberg R, Adler S. 1998. Insulin-like growth factor system and the kidney: Physiology, pathophysiology, and therapeutic implications. Am J Kidney Dis 31:901-919.
17. Isshiki K, He Z, Maeno Y, Ma RC, Yasuda Y, Kuroki T, White GS, Patti ME, Weir GC, King GL. 2008. Insulin regulates SOCS2 expression and the mitogenic effect ofIGF-1 in mesangial cells. Kidney Int 74:1434-1443.
18. Juul A. 2003. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113-170.
19. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS. 2005. Histological grading of IgA nephropathy predicting renal outcome: Revisiting H.S. Lee's glomerular grading system. Nephrol Dial Transplant 20:342-348.
20. Lewis CM. 2002. Genetic association studies: design, analysis and interpretation. Brief Bioinform 3:146-153.
21. Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE, Striker LJ. 1999. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: Implications for diabetic nephropathy. Diabetes 48:1638-1644.
22. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N. 2001. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 16:350-355.
23. Nakamura T, Ebihara I, Nagaoka I, Takahashi T, Tomino Y Koide H. 1992. Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy. Am J Nephrol12:292-302.
24. Nakanishi K, Sako M, Yata N, Aoyagi N, Nozu K, Tanaka R, Iijima K, Yoshikawa N. 2004. A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy. Pediatr Nephrol 19:144-147.
25. Prevot A, Julita M, Tung DK, Mosig D. 2009. Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit. Pediatr Nephrol 24:973-981.
26. Rabkin R, Schaefer F. 2004. New concepts: Growth hormone, insulin-like growth factor-I and the kidney. Growth Horm IGF Res 14:270-276.
27. Rogers SA, Powell-Braxton L, Hammerman MR. 1999. Insulin-like growth factor I regulates renal development in rodents. Dev Genet 24:293-298.
28. Sole X, Guino E, Valls J, Iniesta R, Moreno V. 2006. SNPStats: A web tool for the analysis of association studies. Bioinformatics 22:1928-1929.
29. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
30. Tack I, Elliot SJ, Potier M, Rivera A, Striker GE, Striker LJ. 2002. Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice. Diabetes 51:182-188.
31. Trachtman H, Futterweit S, Schwob N, Maesaka J, Valderrama E. 1993. Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats. Kidney Int 44:1281-1288.